Company news

ValiRx PLC news in 2022

ValiRx PLC's news releases, calls and decks from 2022, newest first.

View company

Shareholder Communications and Investor Webinar

December 6, 2022

Quarterly Operational and Strategy Update

December 6, 2022

Subsidiary Launched and IP License Signed

October 24, 2022

Issue of Share Options

October 18, 2022

Director Appointment

October 11, 2022

Live Shareholder Q&A and industry events

September 22, 2022

Appointment of Interim Chief Scientific Officer

September 8, 2022

Shareholder Communications

August 17, 2022

Successful evaluation of breast cancer programme

July 13, 2022

Director/PDMR Shareholding

July 7, 2022

Broker Option Results

July 5, 2022

Result of AGM and Appointment of Joint Broker

June 30, 2022

Issue of Equity

June 30, 2022

Extends exclusivity period for TheoremRx

June 30, 2022

Update on VAL201 sub-license agreement

June 17, 2022

Annual Report, AGM Notice & Director Resignation

June 7, 2022

Operational and Strategy Update

March 15, 2022

Evaluation agreement with University of Barcelona

February 14, 2022

Signs Service Agreement with TheoremRx

January 5, 2022

Decks in 2022